OpenURL Connection Search

Select item for more details and to access through your institution.

IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren's syndrome.
Published in:
Reumatismo, 2013, v. 65, n. 4, p. 192, doi. 10.4081/reumatismo.2013.192
By:
- Alunno, A.;
- Bistoni, O.;
- Bartoloni Bocci, E.;
- Caterbi, S.;
- Bigerna, B.;
- Pucciarini, A.;
- Tabarrini, A.;
- Mannucci, R.;
- Beghelli, D.;
- Falini, B.;
- Gerli, R.
Publication type:
Article
A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.
Published in:
Leukemia (08876924), 2009, v. 23, n. 3, p. 501, doi. 10.1038/leu.2008.326
By:
- Bolli, N.;
- De Marco, M. F.;
- Martelli, M. P.;
- Bigerna, B.;
- Pucciarini, A.;
- Rossi, R.;
- Mannucci, R.;
- Manes, N.;
- Pettirossi, V.;
- Pileri, S. A.;
- Nicoletti, I.;
- Falini, B.
Publication type:
Article
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia.
Published in:
2008
By:
- Martelli, M. P.;
- Manes, N.;
- Liso, A.;
- Pettirossi, V.;
- Galletti, B. Verducci;
- Bigerna, B.;
- Pucciarini, A.;
- De Marco, M. F.;
- Pallotta, M. T.;
- Bolli, N.;
- Sborgia, M.;
- di Raimondo, F.;
- Fabbiano, F.;
- Meloni, G.;
- Specchia, G.;
- Martelli, M. F.;
- Falini, B.
Publication type:
Letter
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): A comparison with NPMc+ AML.
Published in:
2006
By:
- Falini, B;
- Bigerna, B;
- Pucciarini, A;
- Tiacci, E;
- Mecucci, C;
- Morris, S.W.;
- Bolli, N;
- Rosati, R;
- Hanissian, S;
- Ma, Z;
- Sun, Y;
- Colombo, E;
- Arber, D.A.;
- Pacini, R;
- La Starza, R;
- Galletti, B.V.;
- Liso, A;
- Martelli, M.P.;
- Diverio, D;
- Pelicci, P.-G.
Publication type:
Correction Notice
Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): A comparison with NPMc+ AML.
Published in:
2006
By:
- Falini, B.;
- Bigerna, B.;
- Pucciarini, A.;
- Tiacci, E.;
- Mecucci, C.;
- Morris, S. W.;
- Bolli, N.;
- Rosati, R.;
- Hanissian, S.;
- Ma, Z.;
- Sun, Y.;
- Colombo, E.;
- Arber, D. A.;
- Pacini, R.;
- La Starza, R.;
- Galletti, B. V.;
- Liso, A.;
- Martelli, M. P.;
- Diverio, D.;
- Pelicci, P-G.
Publication type:
Letter
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin.
Published in:
Leukemia (08876924), 2005, v. 19, n. 10, p. 1760, doi. 10.1038/sj.leu.2403899
By:
- Quentmeier, H.;
- Martelli, M. P.;
- Dirks, W. G.;
- Bolli, N.;
- Liso, A.;
- MacLeod, R. A. F.;
- Nicoletti, I.;
- Mannucci, R.;
- Pucciarini, A.;
- Bigerna, B.;
- Martelli, M. F.;
- Mecucci, C.;
- Drexler, H. G.;
- Falini, B.
Publication type:
Article
In vivo targeting of Hodgkin and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2 (CD30): immimohistological evidence.
Published in:
British Journal of Haematology, 1992, v. 82, n. 1, p. 38, doi. 10.1111/j.1365-2141.1992.tb04591.x
By:
- Falini, B.;
- Flenghi, L.;
- Fedeli, L.;
- Broe, M. K.;
- Bonino, C.;
- Stein, H.;
- Düurkop, H.;
- Bigerna, B.;
- Barbabietola, G.;
- Venturi, S.;
- Aversa, F.;
- Pizzolo, G.;
- Bartoli, A.;
- Pileri, S.;
- Sabattini, E.;
- And, R. Palumbo;
- Martelli, M. F.
Publication type:
Article

Found: 7

IL-17-producing double-negative T cells are expanded in the peripheral blood, infiltrate the salivary gland and are partially resistant to corticosteroid therapy in patients with Sjögren's syndrome.

A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF.

A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia.

Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): A comparison with NPMc+ AML.

Aberrant subcellular expression of nucleophosmin and NPM-MLF1 fusion protein in acute myeloid leukaemia carrying t(3;5): A comparison with NPMc+ AML.

Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin.

In vivo targeting of Hodgkin and Reed-Sternberg cells of Hodgkin's disease with monoclonal antibody Ber-H2 (CD30): immimohistological evidence.